Arrowhead Pharmaceuticals, Inc. (ARWR)
64.19
-0.60
(-0.93%)
USD |
NASDAQ |
Oct 02, 16:00
64.06
-0.13
(-0.20%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Price to Book Value : 19.46 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 19.46 |
| October 01, 2026 | 19.64 |
| September 30, 2026 | 19.84 |
| September 29, 2026 | 20.09 |
| September 28, 2026 | 19.85 |
| September 25, 2026 | 19.98 |
| September 24, 2026 | 20.03 |
| September 23, 2026 | 20.30 |
| September 22, 2026 | 21.79 |
| September 21, 2026 | 20.86 |
| September 18, 2026 | 20.15 |
| September 17, 2026 | 20.54 |
| September 16, 2026 | 19.95 |
| September 15, 2026 | 21.43 |
| September 14, 2026 | 24.46 |
| September 11, 2026 | 25.12 |
| September 10, 2026 | 25.09 |
| September 09, 2026 | 25.05 |
| September 08, 2026 | 25.80 |
| September 04, 2026 | 26.18 |
| September 03, 2026 | 26.22 |
| September 02, 2026 | 25.88 |
| September 01, 2026 | 25.08 |
| August 31, 2026 | 24.98 |
| August 28, 2026 | 25.74 |
| Date | Value |
|---|---|
| August 27, 2026 | 26.86 |
| August 26, 2026 | 27.02 |
| August 25, 2026 | 26.95 |
| August 24, 2026 | 26.29 |
| August 21, 2026 | 26.41 |
| August 20, 2026 | 26.52 |
| August 19, 2026 | 27.11 |
| August 18, 2026 | 26.65 |
| August 17, 2026 | 26.89 |
| August 14, 2026 | 26.27 |
| August 13, 2026 | 25.95 |
| August 12, 2026 | 26.45 |
| August 11, 2026 | 27.06 |
| August 10, 2026 | 26.78 |
| August 07, 2026 | 26.57 |
| August 06, 2026 | 26.02 |
| August 05, 2026 | 26.35 |
| August 04, 2026 | 27.16 |
| August 03, 2026 | 26.08 |
| July 31, 2026 | 25.66 |
| July 30, 2026 | 26.47 |
| July 29, 2026 | 26.14 |
| July 28, 2026 | 26.01 |
| July 27, 2026 | 25.93 |
| July 24, 2026 | 25.95 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Sarepta Therapeutics, Inc. | 1.210 |
| Moderna, Inc. | 11.21 |
| Revolution Medicines, Inc. | 16.99 |
| Intellia Therapeutics, Inc. | 2.359 |
| Denali Therapeutics, Inc. | 3.826 |
Price to Book Value Related Metrics
| PS Ratio | 13.48 |
| PEG Ratio | -0.369 |
| Price | 64.19 |
| Earnings Yield | -3.49% |
| Market Cap | 9.059B |
| PEGY Ratio | -0.369 |